Cargando…

Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk

BACKGROUND: Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even within the same age group, which may reflect heterogeneity in biological tissue aging between people. Epigenetic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Maden, Sean K., Luebeck, Georg E., Li, Christopher I., Newcomb, Polly A., Ulrich, Cornelia M., Joo, Ji-Hoon E., Buchanan, Daniel D., Milne, Roger L., Southey, Melissa C., Carter, Kelly T., Willbanks, Amber R., Luo, Yanxin, Yu, Ming, Grady, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942339/
https://www.ncbi.nlm.nih.gov/pubmed/31900199
http://dx.doi.org/10.1186/s13148-019-0801-3
_version_ 1783484684250906624
author Wang, Ting
Maden, Sean K.
Luebeck, Georg E.
Li, Christopher I.
Newcomb, Polly A.
Ulrich, Cornelia M.
Joo, Ji-Hoon E.
Buchanan, Daniel D.
Milne, Roger L.
Southey, Melissa C.
Carter, Kelly T.
Willbanks, Amber R.
Luo, Yanxin
Yu, Ming
Grady, William M.
author_facet Wang, Ting
Maden, Sean K.
Luebeck, Georg E.
Li, Christopher I.
Newcomb, Polly A.
Ulrich, Cornelia M.
Joo, Ji-Hoon E.
Buchanan, Daniel D.
Milne, Roger L.
Southey, Melissa C.
Carter, Kelly T.
Willbanks, Amber R.
Luo, Yanxin
Yu, Ming
Grady, William M.
author_sort Wang, Ting
collection PubMed
description BACKGROUND: Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even within the same age group, which may reflect heterogeneity in biological tissue aging between people. Epigenetic clocks based on DNA methylation are a useful measure of the biological aging process with the potential to serve as a biomarker of an individual’s susceptibility to age-related diseases such as CRC. METHODS: We conducted a genome-wide DNA methylation study on samples of normal colon mucosa (N = 334). Subjects were assigned to three cancer risk groups (low, medium, and high) based on their personal adenoma or cancer history. Using previously established epigenetic clocks (Hannum, Horvath, PhenoAge, and EpiTOC), we estimated the biological age of each sample and assessed for epigenetic age acceleration in the samples by regressing the estimated biological age on the individual’s chronological age. We compared the epigenetic age acceleration between different risk groups using a multivariate linear regression model with the adjustment for gender and cell-type fractions for each epigenetic clock. An epigenome-wide association study (EWAS) was performed to identify differential methylation changes associated with CRC risk. RESULTS: Each epigenetic clock was significantly correlated with the chronological age of the subjects, and the Horvath clock exhibited the strongest correlation in all risk groups (r > 0.8, p < 1 × 10(−30)). The PhenoAge clock (p = 0.0012) revealed epigenetic age deceleration in the high-risk group compared to the low-risk group. CONCLUSIONS: Among the four DNA methylation-based measures of biological age, the Horvath clock is the most accurate for estimating the chronological age of individuals. Individuals with a high risk for CRC have epigenetic age deceleration in their normal colons measured by the PhenoAge clock, which may reflect a dysfunctional epigenetic aging process.
format Online
Article
Text
id pubmed-6942339
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69423392020-01-07 Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk Wang, Ting Maden, Sean K. Luebeck, Georg E. Li, Christopher I. Newcomb, Polly A. Ulrich, Cornelia M. Joo, Ji-Hoon E. Buchanan, Daniel D. Milne, Roger L. Southey, Melissa C. Carter, Kelly T. Willbanks, Amber R. Luo, Yanxin Yu, Ming Grady, William M. Clin Epigenetics Research BACKGROUND: Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even within the same age group, which may reflect heterogeneity in biological tissue aging between people. Epigenetic clocks based on DNA methylation are a useful measure of the biological aging process with the potential to serve as a biomarker of an individual’s susceptibility to age-related diseases such as CRC. METHODS: We conducted a genome-wide DNA methylation study on samples of normal colon mucosa (N = 334). Subjects were assigned to three cancer risk groups (low, medium, and high) based on their personal adenoma or cancer history. Using previously established epigenetic clocks (Hannum, Horvath, PhenoAge, and EpiTOC), we estimated the biological age of each sample and assessed for epigenetic age acceleration in the samples by regressing the estimated biological age on the individual’s chronological age. We compared the epigenetic age acceleration between different risk groups using a multivariate linear regression model with the adjustment for gender and cell-type fractions for each epigenetic clock. An epigenome-wide association study (EWAS) was performed to identify differential methylation changes associated with CRC risk. RESULTS: Each epigenetic clock was significantly correlated with the chronological age of the subjects, and the Horvath clock exhibited the strongest correlation in all risk groups (r > 0.8, p < 1 × 10(−30)). The PhenoAge clock (p = 0.0012) revealed epigenetic age deceleration in the high-risk group compared to the low-risk group. CONCLUSIONS: Among the four DNA methylation-based measures of biological age, the Horvath clock is the most accurate for estimating the chronological age of individuals. Individuals with a high risk for CRC have epigenetic age deceleration in their normal colons measured by the PhenoAge clock, which may reflect a dysfunctional epigenetic aging process. BioMed Central 2020-01-03 /pmc/articles/PMC6942339/ /pubmed/31900199 http://dx.doi.org/10.1186/s13148-019-0801-3 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wang, Ting
Maden, Sean K.
Luebeck, Georg E.
Li, Christopher I.
Newcomb, Polly A.
Ulrich, Cornelia M.
Joo, Ji-Hoon E.
Buchanan, Daniel D.
Milne, Roger L.
Southey, Melissa C.
Carter, Kelly T.
Willbanks, Amber R.
Luo, Yanxin
Yu, Ming
Grady, William M.
Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
title Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
title_full Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
title_fullStr Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
title_full_unstemmed Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
title_short Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
title_sort dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942339/
https://www.ncbi.nlm.nih.gov/pubmed/31900199
http://dx.doi.org/10.1186/s13148-019-0801-3
work_keys_str_mv AT wangting dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT madenseank dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT luebeckgeorge dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT lichristopheri dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT newcombpollya dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT ulrichcorneliam dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT joojihoone dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT buchanandanield dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT milnerogerl dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT southeymelissac dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT carterkellyt dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT willbanksamberr dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT luoyanxin dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT yuming dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk
AT gradywilliamm dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk